Chemical inhibitors of 4933403F05Rik include a range of compounds that target various signaling pathways and kinases, which are crucial for the functional activity of the protein. Staurosporine is a potent protein kinase inhibitor that hinders the ATP binding site ubiquitous among kinases, which can lead directly to the functional inhibition of 4933403F05Rik by preventing necessary phosphorylation events. Similarly, Bisindolylmaleimide I selectively targets Protein Kinase C, which is responsible for a multitude of cellular functions, including phosphorylation processes in which 4933403F05Rik may play a part. The inhibition of PKC by Bisindolylmaleimide I would likely decrease phosphorylation events that are essential for 4933403F05Rik's activity. Rapamycin, an mTOR inhibitor, is known to play a significant role in cell growth and proliferation; by inhibiting mTOR, Rapamycin can reduce the activity of 4933403F05Rik, as mTOR is part of the signaling pathway that regulates this protein's function.
Further, LY294002 and Wortmannin both serve as PI3K inhibitors, which curtails AKT phosphorylation and the downstream signaling that can involve 4933403F05Rik, leading to a decrease in the protein's functional activity. PD98059 and U0126, both MEK inhibitors, suppress ERK activation and constrain the signaling that may be necessary for 4933403F05Rik's operation. SB203580's inhibition of p38 MAP kinase and SP600125's inhibition of JNK both serve to attenuate signaling pathways, which include 4933403F05Rik, thereby inhibiting its activity. PP2, a Src family tyrosine kinase inhibitor, could also reduce multiple signaling pathways that are essential for the functional activation of 4933403F05Rik. Y-27632 inhibits ROCK kinase, which is involved in various cellular structures and functions; its inhibition can lead to a reduction in signaling cascades that are necessary for the activity of 4933403F05Rik. Lastly, PD173074 directly inhibits FGFR1 kinase, altering the signaling pathways that involve 4933403F05Rik and leading to the suppression of its activity. Each chemical plays a role in meticulously dismantling the network of signaling required for 4933403F05Rik to function effectively within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Inhibits protein kinases by targeting the ATP binding site, which can lead to the functional inhibition of 4933403F05Rik activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Specific inhibitor of Protein Kinase C (PKC), likely diminishing phosphorylation events that 4933403F05Rik may be involved in. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, which may be part of a pathway for regulating 4933403F05Rik, leading to decreased protein activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, potentially reducing AKT phosphorylation and downstream signaling that could inhibit 4933403F05Rik activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which may reduce ERK activation and downstream signaling, possibly inhibiting 4933403F05Rik activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAP Kinase inhibitor, likely to reduce signaling pathways that could be involved in the functional activity of 4933403F05Rik. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, which can attenuate signaling pathways that include 4933403F05Rik, leading to its functional inhibition. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family tyrosine kinase inhibitor, could reduce multiple signaling pathways that include functional activation of 4933403F05Rik. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2, potentially reducing ERK activation and downstream signaling affecting 4933403F05Rik activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor, may diminish downstream AKT phosphorylation and signaling pathways involving 4933403F05Rik. | ||||||